VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 59 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,733,107 | -36.4% | 699,681 | -1.4% | 1.76% | -24.4% |
| Q2 2023 | $16,878,957 | +22.1% | 709,498 | +30.5% | 2.32% | +30.1% |
| Q1 2023 | $13,829,260 | -54.2% | 543,603 | -47.5% | 1.78% | -61.5% |
| Q4 2022 | $30,223,499 | +47.4% | 1,034,697 | +3.5% | 4.64% | +7.3% |
| Q3 2022 | $20,510,000 | +200.4% | 1,000,000 | +69.5% | 4.32% | +147.8% |
| Q2 2022 | $6,828,000 | -37.4% | 590,143 | +0.1% | 1.74% | -50.7% |
| Q1 2022 | $10,906,000 | +91.6% | 589,826 | +104.8% | 3.54% | +16.3% |
| Q4 2021 | $5,692,000 | – | 287,934 | – | 3.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 944,092 | $15,530,000 | 5.65% |
| Ally Bridge Group (NY) LLC | 904,978 | $14,887,000 | 4.38% |
| COMMODORE CAPITAL LP | 667,674 | $10,983,000 | 2.90% |
| FRAZIER MANAGEMENT LLC | 1,505,200 | $24,761,000 | 1.98% |
| Logos Global Management LP | 1,500,000 | $24,675,000 | 1.78% |
| Ghost Tree Capital, LLC | 350,000 | $5,758,000 | 1.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 106,078 | $1,745,000 | 0.99% |
| Vivo Capital, LLC | 1,300,000 | $21,385,000 | 0.96% |
| ACUTA CAPITAL PARTNERS, LLC | 135,807 | $2,234,000 | 0.79% |
| BVF INC/IL | 804,126 | $13,228,000 | 0.52% |